New Alzheimer’s Drug Raises Hopes — Along With Questions
(By Judith Graham for KFF Health News) The FDA has approved Leqembi, the first disease-modifying treatment for early-stage Alzheimer’s and
Read More(By Judith Graham for KFF Health News) The FDA has approved Leqembi, the first disease-modifying treatment for early-stage Alzheimer’s and
Read More(By Rylee Wilson for Becker’s Hospital Review) CMS is proposing broader coverage of PET scans for patients with Alzheimer’s disease,
Read More(By Arthur Allen for KFF Health News) This week the FDA is expected to approve what many scientists and doctors
Read More(By Kerry Dooley Young for STAT) Medicare’s decision to withhold coverage for Biogen’s Aduhelm despite the Food and Drug Administration’s
Read More(By Rylee Wilson for Becker’s Hospital Review) Twenty-six state attorneys general are asking Medicare to cover monoclonal antibody treatments for
Read More(By Jon Hamilton and Aaron Scott for NPR) Researchers are launching a make-or-break study to test the conventional wisdom about
Read More